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Bypass to plantar and tarsal arteries: An acceptable
approach to limb salvage
Kakra Hughes, MD, Christoph M. Domenig, MD, Allen D. Hamdan, MD, Marc Schermerhorn, MD,
Bernadette Aulivola, MD, Seth Blattman, MD, David R. Campbell, MD, Sherry D. Scovell, MD, Frank
W. LoGerfo, MD, and Frank B. Pomposelli, Jr, MD, Boston, Mass
Objective: This study was undertaken to evaluate our experience with distal arterial bypass to the plantar artery branches
and the lateral tarsal artery for ischemic limb salvage.
Methods: This was a retrospective analysis of data prospectively entered into our vascular surgery database from January
1990 to January 2003 for all consecutive patients undergoing bypass grafting to the plantar artery branches or the lateral
tarsal artery. Median follow-up was 9 months (range, 1-112 months). Demographic data, indications for surgery,
outcomes, and patency were recorded, and statistical analysis was performed to assess significance.
Results: Ninety-eight bypass procedures to either the medial plantar artery, lateral plantar artery, or lateral tarsal artery
were performed in 90 patients. Eighty-one patients (83%) were men. Mean age was 67.5  11.6 years. Indications for
operation were tissue loss in 93 patients (95%), rest pain in 3 patients (3%), and failing graft in 2 patients (2%). Eighteen
patients (18%) had previously undergone vascular reconstruction, and 5 patients (5%) had undergone previous bypass to
the dorsalis pedis artery. Seventy-one grafts (72%) had inflow from the popliteal artery, 25 grafts had inflow from a
femoral artery or graft (26%), and 2 grafts had inflow from a tibial artery (2%). Conduits used were greater saphenous vein
in 67 patients (69%), arm vein in 20 patients (20%), composite vein in 10 patients (10%), and polytetrafluoroethylene
conduit in 1 patient (1%). There were 77 bypasses (79%) to plantar artery branches, and 21 bypasses (21%) to the lateral
tarsal artery. Thirty-day mortality was 1% (1 of 98 procedures). Early graft failure within 30 days occurred in 11 patients
(11%). In the subset of patients with a previous arterial reconstruction, there were 2 early graft failures within 30 days
(11%). Both occurred in patients who had undergone previous bypass to the dorsalis pedis artery. Primary patency,
secondary patency, limb salvage, and patient survival were 67%, 70%, 75%, and 91%, respectively, at 12 months, and 41%,
50%, 69%, and 63%, respectively, at 5 years, as determined from Kaplan-Meier survival curves. Greater saphenous vein
grafts performed better than all other conduits, with a secondary patency rate of 82% versus 47% at 1 year (P  .009).
Conclusion: Inframalleolar bypass to plantar artery branches and the lateral tarsal artery, even in patients with a previously
failed revascularization, can be undertaken with acceptable patency and limb salvage rates. Early graft failure, however,
is higher, whereas patency and limb salvage rates are lower, compared with bypass to the dorsalis pedis artery. The use of
saphenous vein as a conduit results in the best patency for plantar or lateral tarsal bypass procedures. ( J Vasc Surg 2004;
40:1149-57.)Distal vein bypass to the dorsalis pedis artery and para-
malleolar posterior tibial artery are now routine procedures
for most vascular surgeons. These operations are most
commonly performed to treat ischemic foot complications
of diabetes mellitus because of the unique pattern of ath-
erosclerosis in these patients. In detailed anatomic studies
of amputated limbs from patients with diabetes mellitus,
Conrad1 recognized that even in the presence of extensive
tibial and peroneal occlusive disease most limbs had relative
sparing of the major foot arteries, especially the dorsalis
pedis artery. In our own practice, in which nearly 90% of
patients with critical foot ischemia have diabetes, vein by-
pass to the dorsalis pedis artery has been the singlemost
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30% of all lower extremity arterial reconstructions.2
Occasionally patients have critical foot ischemia at pre-
sentation, and when examined it is found that both the
dorsalis pedis artery and the paramalleolar posterior tibial
artery are occluded, with only branches of these vessels,
namely, the tarsal and plantar arteries, remaining patent
(Figs 1 and 2). Although the technical feasibility of bypass
to pedal branch arteries was demonstrated more than 15
years ago,3 published series have been small.3-6 In our
experience, we have performed bypasses to the plantar
branches and lateral tarsal artery when no other bypass
option was feasible and we believed major amputation was
the only other treatment option. We undertook this study
to review our overall experience with plantar and lateral
tarsal bypass with regard to traditional outcome measures
of patency, limb salvage, and mortality and to evaluate our
results in comparison with our much larger experience with
dorsalis pedis bypass.
PATIENTS and METHODS
Data collection. Since 1990, pertinent clinical data
for all consecutive patients undergoing lower extremity
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December 20041150 Hughes et alFig 1. Preoperative anteroposterior (A) and lateral (B) arterio-
grams of foot of patient undergoing plantar artery bypass.Fig 2. Preoperative anteroposterior (A) and lateral (B) arterio-
grams in a patient undergoing lateral tarsal artery bypass. Note
stump of occluded dorsalis pedis artery.
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Center have been entered into a computerized vascular
registry. For this study the registry was queried to identify
those patients who had a plantar or tarsal artery as an
outflow target up to January 2003. Bypasses identified as
plantar or tarsal included those that extended only to the
plantar bifurcation or the takeoff of the lateral tarsal artery,
provided the distal portion of the anastomosis terminated
in either of the plantar branches or the lateral tarsal artery,
as well as those in which the distal anastomosis was fash-
ioned in its entirety in one of the plantar branches or the
lateral tarsal artery. All data were prospectively entered at
the time of treatment, and the registry was updated period-
ically with patient follow-up data. Initial data included
demographics, indications for surgery, comorbid condi-
tions, specific operative details, complications, and out-
come at discharge from the hospital. Follow-up data in-
cluded outcomes, graft patency, dates and nature of any
graft revision, dates of graft occlusion, and dates of major
amputation or death. Retrospective query of the database
and chart reviews were performed.
Patient follow-up. Patients were followed up at regular
intervals of approximately every 3months during the first year,
every 6 months during the second year, and annually thereaf-
ter. Graft patency was determined by the presence of a palpa-
ble pulse in the graft by the attending surgeon. Duplex vein
graft surveillance was not routinely used during the study.
Limb salvage was defined as preservation of enough of the
foot to allow ambulation without the need of a prosthetic.
This included feet requiring toe, ray, or transmetatarsal am-
putations, as well as partial or complete resection of the
calcaneous. Death during follow-up was determined from the
Social Security Death Index.
Statistical analysis. Patient demographic data, indica-
tions for surgery, details of the surgical procedure, and
follow-up data were analyzed with a commercially available
statistics software program (Statview 5.0 software; SAS
Institute). All data are presented in accordance with the
revised reporting standards of the Joint Council of the
Society for Vascular Surgery and the American Association
of Vascular Surgery.7 Graft patency, limb salvage, and
patient survival were calculated with the Kaplan-Meier life
table method. Comparisons were made with the nonpara-
metric Mantel-Cox log-rank test. Categorical variables
were compared with the 2 test, and continuous variables
with the Student t test. P .05 was considered statistically
significant.
Patient selection and surgical management. Only
patients with signs and symptoms of limb-threatening isch-
emia were considered for plantar or lateral tarsal bypass.
When present, active infection was treated intravenously
with broad-spectrum antibiotic agents, and foot debride-
ment or incision and drainage, as needed, before arterial
reconstruction. Infectious diseases and podiatry services
were often consulted to assist in patient management.
Selection criteria for lateral tarsal or plantar bypass were
determined from preoperative intraarterial digital subtrac-
tion angiograms. Magnetic resonance angiography, com-puted tomography angiography, or arterial duplex ultra-
sound scanning were not used in these patients. Our
standard routine for arterial imaging included the abdom-
inal aorta, bilateral pelvis, and the involved extremity to the
base of the toes. Magnified anterior and posterior, and
lateral projections of the foot vessels were routinely ob-
tained. Occasionally intraarterial vasodilator agents (nitro-
glycerin 400g/mL or papaverine 60-90mg) were admin-
istered during angiography to enhance imaging of the
distalmost foot vessels.8 Plantar or lateral tarsal bypass was
chosen only when there was no angiographic evidence of a
more proximal outflow target that would enable the foot to
heal. In general, the plantar branch or lateral tarsal artery
with the largest caliber and least disease was chosen as the
outflow target. Our approach to plantar and lateral tarsal
bypass is similar to that for dorsalis pedis reconstruction, as
described.9,10We rely on use of distal inflow sites and short,
translocated greater saphenous vein grafts whenever possi-
ble. In situ saphenous vein bypass was performed when the
bypass originated from the common or superficial femoral
artery and the greater saphenous vein was intact. Reversed
or nonreversed translocated greater saphenous vein grafts
were used for bypasses originating from the popliteal or
tibial arteries. The configuration of the saphenous vein was
chosen to optimize the match in caliber between the con-
duit and the inflow and outflow arteries.10 In the absence of
ipsilateral greater saphenous vein, our conduit of choice
was arm vein,11 followed by lesser saphenous vein. Com-
posite grafts composed of different vein segments con-
nected with end-to-end venovenostomies were occasion-
ally used. Angioscopy was routinely used to prepare the
vein grafts and to confirm their adequacy as conduits. In the
later years of the study preoperative duplex ultrasound vein
mapping was frequently used to identify suitable venous
conduits.
Exposure of the lateral tarsal artery was accomplished
with a longitudinal incision on the dorsum of the foot. The
dorsalis pedis artery was exposed first; the takeoff point of
the lateral tarsal branch was identified at the level of the
navicular bone, and the incision was extended in a slightly
lateral direction to expose it completely. The extensor
digitorum longus tendons were retracted laterally, and the
belly of the extensor hallucis brevis muscle was partially
incised to facilitate exposure. The plantar vessels were ex-
posed through an incision posterior to the medial malleo-
lus. The very distal posterior tibial artery would be identi-
fied first, and the incision and dissection extended distally,
dividing the flexor retinaculum and several crossing veins to
expose the plantar bifurcation. In general, the medial plan-
tar branch continues in a straight course from the bifurca-
tion along the medial sole of the foot. Division of the
abductor hallucis muscle is usually required to facilitate
exposure. The lateral plantar artery takes a slightly more
inferior course to the medial plantar artery and is often
larger. Usually a segment suitable for bypass can be exposed
before it courses laterally across the sole of the foot. Direct
exposure of the plantar branches or lateral tarsal artery was
heart
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small silicone rubber vessel loops, intra-arterial vessel oc-
cluders, or sterile tourniquets,12 at the discretion of the
attending surgeon. Most plantar and lateral tarsal arteries
were calcified to some degree, and some were circumferen-
tially calcified.13 Occasionally the target artery was opened
before harvesting the vein, to determine its suitability for
bypass. In general, plantar and lateral tarsal arteries were
considered suitable if the internal lumen was large enough
to permit gentle passage of a 1-mm stainless steel coronary
probe or 22-gauge intravenous cannula, some back bleed-
ing was present, and injection of normal saline solution or
heparin solution into the artery through a 22-gauge intra-
venous cannula with a 10-mL syringe did not meet exces-
sive resistance. Some outflow target vessels were smaller
than 1 mm. Anastomoses were performed with small-cali-
ber 7-0 or 8-0 polypropylene sutures on fine stainless steel
needles with taper-cut points under 2.5 or 3.5 loupe
magnification. Completion arteriography was rarely per-
formed; however, all grafts were interrogated with a sterile
hand-held continuous wave Doppler probe to assess the
presence and adequacy of blood flow.
Foot wounds were closed in a single layer with an absorb-
able subcuticular suture or a simple interruptedmonofilament
skin suture. Postoperatively, patients were given aspirin and
subcutaneous heparin 5000 U every 8 to 12 hours until
discharge. Other antiplatelet agents, such as clopidogrel, and
systemic anticoagulation were not routinely used. Some pa-
tients were given low-molecular-weight dextran intravenously
at a rate of 20 mL/hr for 48 hours after surgery, at the
discretion of the attending surgeon. Careful attention was
given to minimize the significant foot edema that usually
accompanies these bypass procedures and is a major cause of
wound complications. This was done with elastic wraps, re-
stricting weight bearing for 2 to 7 days, and encouraging
Table 1. Clinical characteristics and surgical indications fo
Study group
No. of patients 98
Demographics
Age 67.5  11.57
Male gender 81 (83%)
Diabetes 82 (84%)
Hypertension 56 (57%)
CAD 39 (40%)
Prior MI 32 (33%)
CHF 15 (15%)
Prior CABG 21 (21%)
Cr 2mg/dL 13 (13%)
Dialysis 4 (4%)
Current smoker 17 (17%)
Indications
Tissue loss 93 (95%)
Rest pain 3 (3%)
Failing graft 2 (2%)
CAD, Coronary artery disease; MI, myocardial infarction; CHF, congestive
*Student t test, all other P values generated with 2.frequent leg elevation in the first few postoperative weeks.RESULTS
Over 13 years 124 bypasses were performed to the
medial plantar, lateral plantar, or lateral tarsal artery. This
represented 2.62% of the 4732 lower extremity arterial
bypasses performed at our institution during this period. In
98 patients complete follow-up was available, and this
group formed the basis of the study. Comparisons, how-
ever, were performed to ensure that this study group was
representative of the entire population who underwent
plantar or lateral tarsal artery bypass. Patient characteristics
are shown in Table I, and are compared with the population
lost to follow-up. Patients who composed the study sample
were comparable to the population lost to follow-up in
every category except prevalence of congestive heart failure.
Mean age of the study population was 67.5 years in a
primarily male population (83%). Eighty-four percent of
patients had diabetes mellitus. A substantial number of
patients had cardiac comorbid conditions, and renal insuf-
ficiency (defined as serum creatinine concentration 2
mg/dL) was present in 13% of patients at operation. Eigh-
teen patients (18%) had undergone previous arterial bypass
in the involved extremity. In 5 of these patients the bypass
was to the dorsalis pedis artery. All dorsalis pedis bypasses
were occluded at the time of plantar or lateral tarsal bypass.
Indications for surgery were tissue loss in 95% of patients,
rest pain in 3%, and failing graft in 2% (Table I). Table II
lists the conduits, inflow and outflow arteries, as compared
with the population lost to follow-up. The study group was
comparable to the population lost to follow-up in every
category except use of a tibial inflow site. Autogenous vein
was used in all but 1 patient. The popliteal artery was the
inflow site in 72% of procedures. Outflow arteries selected
were the lateral tarsal artery in 21.4%, the medial plantar
artery in 24.5%, and the lateral plantar artery in 19.4%. In
ients undergoing plantar/lateral tarsal artery bypass
Lost to follow-up P value
26
66  13.29 .78*
21 (81%) .82
22 (85%) .91
20 (70%) .06
16 (62%) .47
17 (65%) .85
11 (42%) .05
8 (31%) .32
4 (15%) .68
1 (4%) .96
3 (12%) .47
23 (88%) .24
2 (8%) .29
1 (4%) .59
failure; CABG, coronary artery bypass grafting.r pat34.7% the specific plantar branch outflow artery could not
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more than half of cases the arteries were moderately to
heavily calcified, with 15% requiring use of intraluminal
occluders or tourniquets. Median hospital stay was 10.5
days (range, 2-30 days).
Table III lists the perioperative complications as com-
pared with the population lost to follow-up. The 2 groups do
not statistically differ with regard to perioperative complica-
tions. In the study population, there was 1 death within 30
days of operation. This occurred on postoperative day 3 in a
patient with end-stage renal failure who was receiving hemo-
dialysis. Myocardial infarction occurred in 2 patients. Other
complications included overt congestive heart failure in 1
patient and renal failure in 1 patient. Early graft failure oc-
curred after 11 operations (11%). Of these, 8 resulted in the
need for major amputation, including 6 in which the graft
failed and amputation was performed without any attempt to
salvage the graft, and2others inwhich an attempt to revise the
graft was unsuccessful and amputation was performed within
2 months of the initial bypass procedure. In 3 patients the
graft failed immediately; no attempt at graft revision was
Table II. Conduits, inflow and outflow arteries
Study
No. of procedures 98
Conduit
Reversed saphenous 29 (3
Nonreversed saphenous 27 (2
Arm vein 20 (2
In situ saphenous 11 (1
Composite vein 10 (1
PTFE 1 (1
Inflow artery
Below-knee popliteal 58 (5
Above-knee popliteal 13 (1
Common femoral 12 (1
Vein graft 9 (9
Superficial femoral 3 (3
Tibial artery 2 (2
Prosthetic graft 1 (1
Outflow artery
Medial plantar 24 (2
Lateral plantar 19 (1
Plantar (unknown medial or lateral) 34 (3
Lateral tarsal 21 (2
PTFE, Polytetrafluoroethylene.
Table III. Perioperative complications
All patients
No. of patients 124
Early graft failure 12 (9.7%)
Symptomatic MI 2 (1.6%)
Mortality 2 (1.6%)
Congestive heart failure 2 (1.6%)
Renal failure 2 (1.6%)
MI, Myocardial infarction.made, but major amputation was not necessary, and thepatients continued to be ambulatory at follow-up intervals of
32 months, 6 months, and 1 month, respectively. One of the
early graft failures was in our single patient in the series with a
polytetrafluoroethylene conduit . No attempt at graft revision
was made in this patient, and below-knee amputation was
performed 6 months after bypass. During follow-up, which
ranged from 1 to 112 months (median, 9 months), primary
patency, secondary patency, and limb salvage rates were 67%,
70%, and 75%, respectively, at 1 year, and 41%, 50%, and 69%,
respectively, at 5 years (Fig 3 and Fig 4, A). Patient survival
was 91% at 1 year and 63% at 5 years (Fig 4, B). Greater
saphenous vein grafts performed better than all other con-
duits, with a primary patency rate of 77% versus 47% and a
secondary patency rate of 82% versus 47% at 1 year (P 
.0089). No differences in patency or limb salvage rates were
demonstrated between medial plantar, lateral plantar, and
lateral tarsal bypass procedures. Univariate analysis iden-
tified use of the greater saphenous vein as the only
significant variable among 25 clinical factors, which was
associated with long-term patency at 1 year after opera-
Lost to follow-up P value
26
9 (35%) .62
10 (38%) .28
3 (12%) .30
3 (12%) .96
1 (4%) .09
0 (0%) .60
13 (50%) .40
4 (15%) .78
4 (15%) .67
1 (4%) .35
0 (0%) .37
4 (15%) .05
0 (0%) .61
3 (12%) .16
2 (8%) .16
14 (54%) .08
7 (27%) .55
group
G)
Lost to follow-up
(LTF)
P value
(SG vs LTF)
8 26
11%) 1 (4%) .26
2%) 0 (0%) .46
1%) 1 (4%) .31
1%) 1 (4%) .31
1%) 1 (4%) .31group
0%)
7%)
0%)
1%)
0%)
%)
9%)
3%)
2%)
%)
%)
%)
%)
5%)
9%)
5%)
1%)Study
(S
9
11 (
2 (
1 (
1 (
1 (tion (Table IV) .
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Technical improvements in lower extremity arterial
reconstructive surgery over the last 3 decades, along with
improvements in anesthetic management, have greatly im-
proved the immediate results after lower extremity greater
saphenous vein bypass grafting, even to very distal target
vessels.6,9,14-18 Ascer et al3 first demonstrated the technical
feasibility of plantar and tarsal bypass in 1988; however, the
number of procedures performed in this and subsequent
series4,5 was small. The current work is a retrospective study
of a primarily diabetic population without complete follow-
Fig 3. Primary patency (A) and secondary patency (B) in patients
with bypass to medial or lateral plantar artery or lateral tarsal artery.
(SE 10% at all time intervals.)up, and represents the largest published series to date. Asthe small study population signifies, this is a rarely per-
formed operation, even in an institution accustomed to
distal arterial bypass procedures. In this study, as in the
others,3-5 this operation is most commonly performed in
patients with diabetes mellitus with extensive infrapopliteal
arterial occlusive disease, similar to those requiring dorsalis
pedis bypass. However, early graft failure in this study was
11%, more than twice that in our patients undergoing
dorsalis pedis bypass2 (Table V) . Patency and limb salvage
rates were also inferior to those obtained in our dorsalis
pedis bypass population (Fig 5) . Ascer et al3 (29%), Roddy
et al6 (26%), and Andros et al5 (15%) also noted a higher
than expected rate of early graft occlusion.Moreover, in the
Fig 4. Limb salvage (A) and patient survival (B) in patients with
bypass to medial or lateral plantar artery or lateral tarsal artery. (SE
10% at all time intervals.)current study only 2 of 11 patients with early graft failure
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peat exploration a technical cause of failure was not identi-
fied in either patient, and it is our impression that failure
was most likely due to poor runoff. Thrombectomy and
vein patch angioplasty performed in each case was unsuc-
cessful. Ultimately, 8 of 11 patients with early graft failure
required amputation, including the 1 patient in whom an
ill-conceived attempt was made to revise a failed dorsalis
pedis bypass with a prosthetic graft. The infrequency of
immediate return to the operating room because of failed
grafts underscores our impression that most of these pro-
cedures represent a “last ditch” effort at limb salvage and
that this probably defines the technical limit of lower ex-
tremity arterial reconstruction. Despite the higher than
expected early failure rate, outcomes in grafts remaining
patent proved quite good. Ascer et al3 reported a primary
patency rate of 67% and a limb salvage rate of 78% (SE,
10%) at 2 years in a series of 24 operations, and Connors et
al4 reported a primary patency rate of 70% and a limb
salvage rate of 78% (SE, 10%) at 2 years in another series of
24 pedal branch arterial bypass procedures. In comparison,
our 5-year secondary patency and limb salvage rates are 50%
and 69%, respectively. The nearly 20% difference between
graft patency and limb salvage is notable, and suggests that
some procedures may have been performed in patients who
may not have had critical ischemia despite a clinical impres-
sion to the contrary. It is possible that neuropathy in
conjunction with moderate ischemia may have had a role in
Table IV. Results of univariate analysis of factors
influencing graft patency at 1 year following bypasses to
the medial plantar, lateral plantar, or lateral tarsal artery
Clinical factor P value
Gender .063
Diabetes .303
Neuropathy .945
Tobacco .631
Coronary artery disease .369
Congestive heart failure .657
Previous myocardial infarction .683
Prior coronary artery bypass surgery 1
Prior percutaneous coronary angioplasty .853
Renal disease .052
Cr 2 .258
Hemodialysis .197
Ulcer .491
Gangrene .366
Infection .499
Rest pain .193
Claudication .341
Failing graft .663
Bypass for occluded graft .276
Revised graft .146
Greater saphenous vein .003
Length of stay 10 days .371
Popliteal inflow .391
Plantar artery .263
Tarsal artery .263
Heel lesion .425causing ulcers or tissue loss in some patients. While neu-ropathy is the antecedent cause of ulcers in such patients, it
is the presence of arterial insufficiency that delays or pre-
vents healing (so-called neuro-ischemic ulcers). In our
experience, many of these patients will require arterial
reconstruction to facilitate wound healing, even though the
degree of ischemia is not severe enough in and of itself to
result in gangrene or amputation. Consequently, arterial
Fig 5. Comparison of secondary patency (A) and limb salvage
(B) between dorsalis pedis bypass and plantar or tarsal bypass
patient populations. (SE 10% at all time intervals.)bypasses to treat neuro-ischemic ulcers will result in foot
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fail, provided the foot has previously healed.
Although the early rate of failure of these procedures is
disappointingly high, it is important to recognize that,
when successful, pedal branch bypass results in durable
limb salvage in most patients. Reconciling the high rate of
early graft failure with the high likelihood of limb salvage
when grafts remain patent underscores the importance of
proper patient selection and begs the question as to
whether there are factors that might predict outcome be-
fore pedal branch bypass is attempted. At univariate analysis
only the use of saphenous vein had an effect on the likeli-
hood of graft patency, although qualitative or quantitative
information about runoff was not available, and many
arteriograms were no longer available for review, 2 major
shortcomings of this study. In general, we have relied on
the appearance of the lateral tarsal or plantar arteries on
arteriograms, using conventional criteria such as vessel di-
ameter and absence of disease in selecting our outflow
target. In this series the plantar branches were more fre-
quently found to be suitable than the lateral tarsal artery as
target arteries, although outcomes for the plantar branches
compared with the lateral tarsal artery proved similar. No
significant difference was noted between medial and lateral
plantar arteries, although the medial plantar branch is an
end artery with presumably worse runoff than the lateral
plantar branch, which connects to the pedal arch. It is
notable, however, that a third of patients in the study had
bypasses to an unspecified plantar artery.
Consequently, until more specific information is avail-
able, the decision of whether to attempt a bypass to a pedal
branch artery remains one of surgical judgment. In patients
facing imminent amputation with no other bypass option,
attempting a bypass to either a plantar branch or the lateral
tarsal artery thought to be of acceptable caliber and quality
is reasonable, provided vein conduit is available and the
foot is salvageable. Patients should be made aware of a
higher likelihood of graft failure than with other more
proximal arterial reconstructions. If the graft should imme-
diately fail, the surgeon should consider a repeat attempt
carefully and with some trepidation. In our experience,
these procedures rarely, if ever, restore patency or result in
Table V. Comparison of 5-year results of bypass to
plantar or lateral tarsal arteries and dorsalis pedis bypass
Plantar or
lateral tarsal
artery (%)
Dorsalis pedis
artery (%) P
Early graft failure 11 4.2 .0017*
Primary patency 41 57 .0004
Secondary patency 50 63 .0001
Limb salvage 69 78 .0001
Patient survival 63 49 .1858
*Comparison with 2 test; all other P values generated with log-rank test
comparing life table curves.limb salvage, and should be avoided in most patients.We acknowledge our media/computer specialist Barry
Gross, database manager Lynn Francis, and administrative
assistant Antoinette Perry, for assistance in preparation of
the manuscript.
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DrDaniel B.Walsh (Lebanon, NH).Mr President, DrHughes
and the Deaconess Group have presented their experience with tarsal
and plantar artery bypasses in 90 patients. As you would expect from
a group with such extensive lower extremity bypass experience, the
results are excellent and match those previously reported.
It is interesting that the authors were initially skeptical
about the utility of such distal bypass procedures, because of an
expected lack of durability. The results must have been
achieved, not only through technical proficiency, but also be-
cause of superior patient selection. The nature of their database
precludes a detailed analysis of targeted runoff vessels and other
important details.
My questions for the authors focus on how they select patients
for these pedal branch artery bypasses now.
First, why were there so few women who underwent this
procedure? Do they continue to advocate these bypasses with
conduits other than the saphenous vein? Would the use of pros-
thetic conduit now be contraindicated, in their minds?
What are the characteristics of usable versus nonusable target
arteries? Is a 1-mm vessel the only selection criteria? Have they any
experience with MRA or duplex scanning criteria for selecting
these vessels in their more contemporaneous experience? Do they
continue to believe the continuous-wave Doppler examination is
an adequate or optimal completion study for confirmation of
technical adequacy and a predictor of patency?
At the time of graft failure, what did they find? What were the
measures that were most often performed and that led to successful
continued patency? Do they still advocate immediate return to the
operating room in all early graft failures?
Dr Kakra Hughes. We do not know why so few women were
treated. Others have noted this finding as well. In the study that
was published by your institution, Dr Walsh, more than 90% of the
population was men. In our series more than 80% were men, and in
a study by Dr Ascher, I believe 77% of patients were men.We don’t
know why this is, but we do not believe that this finding is due to
selection bias for male patients.
As regards conduits, the ipsilateral greater saphenous vein is
our conduit of choice. In its absence we prefer to use an arm vein.
All of our conduits are prepared with angioscopy to determine
their suitability for bypass before proceeding. We discourage the
use of prosthetics, and believe their use is ill-advised.
Concerning the characteristics of usable versus nonusable
target arteries, we rely on complete intraarterial digital subtraction
angiography.We like to see a patent vessel free of significant disease
and including the pedal arch. If the tarsal and plantar arteries are
both suitable, we choose the one with the larger caliber. We also
determine suitability for bypass in the operating room. First, we
like to be able to pass at least a 1-mm coronary probe into the distal
vessel, although this is not always possible, and we have done
bypasses to vessels that are less than 1 mm if we are able to inject
heparinized saline solution into the target vessel with a 22-gauge
angiography catheter and not meet with too much resistance. Of
course, this is subjective. We typically like to see some backbleed-
ing as well. Since many of these determinants are subjective,
surgical experience is also very important.
We do not use MRA or duplex scanning for these very distal
bypasses, but rely exclusively on angiograms, at least at this point.
We do not consider continuous-wave Doppler ultrasound scan-
ning to be a completion study per se. We use it only to ensure that
there is in fact flow in the outflow vessel at completion of theoperation.We have not found completion angiograpy very helpful.
In our experience, most technical failures have been due to prob-
lems with the conduit, and we believe that by using angioscopy and
ensuring that the conduit is adequate we can be reasonably assured
that our technical results will be acceptable. In fact, we looked at
this some years ago, comparing angioscopy with completion an-
giography, though this series was limited to arm vein conduits, and
we found that angioscopy was preferable to completion angiogra-
phy for detecting intraluminal abnormalities (Stonebridge PA,
Miller A, Tsoukas A, Brophy CM, Gibbons GW, Freeman DV, et
al. Angioscopy of arm vein infrainguinal bypass grafts. Ann Vasc
Surg 1991;5:170-5).
Only 2 patients were explored at the time of graft failure. The
cause of graft failure in either patient was not due to technical error,
and was presumed due to inadequate runoff. The other 9 patients
were not explored again, because the surgeon considered the
operation to be technically adequate and that this was the limit of
his or her technical ability. For this reason, the decision was made
at the time of the initial operation not to perform repeat explora-
tion should the graft fail. Most of these patients subsequently
required major amputation.
Dr Enrico Ascher (Brooklyn, NY). Having had the opportu-
nity to do this operation about 18 years ago, I certainly have a
thousand questions for you, but I will limit them to 2 quick ones.
Have you done any pedal arch bypass operations? I ask this
because occasionally we see patients in whom only the pedal arch is
intact, and by removing the body of the second metatarsal bone
you can certainly approach this artery very easily, do the bypass, and
save the patient’s leg.
My second question is, what’s the difference in your results
between the use of the lateral and the medial plantar arteries?
Dr Hughes. Dr Ascher, we are familiar with your technique,
but have not yet encountered a situation where we have used it. To
the best of our knowledge, results were equivalent for medial and
lateral plantar bypasses; however, some records did not specify
which plantar branch was used.
Dr Peter Gloviczki (Rochester, Minn). We found in our
experience that end-stage renal disease, in addition to composite
vein graft, is an independent risk factor for predicting failure. And
you didn’t mention whether end-stage renal disease was a major
player, although I noticed that you didn’t find it to be a predictor.
So my first question is, do you treat those patients differently?
And my second question is on survival. You didn’t mention
the dismal survival of this patient population. We found that in
those patients who have successful revascularization, survival is as
good as 87%, versus those who had failed revascularization and
amputation, with survival at 26%. So I’m wondering if you think
you can improve survival in your patients with distal artery revas-
cularization?
Dr Hughes. Concerning end-stage renal disease, we did not
find that to affect patency in our series; our number of patients with
end-stage renal disease, however, was small.
With survival, we found that patient survival in this population
was very similar to survival in other patients with very distal
bypasses, that is, dorsalis pedis bypasses. We have also observed and
have recently published the dismal survival seen in patients under-
going amputations. Although the survival in patients undergoing
bypass is better, it is unclear whether the bypass itself can explain
this finding.
